Proton versus photon radiation for IDH-mutated brain tumors
Part of Cancer clinical trials.
This trial compares two types of radiation—proton therapy versus photon (standard) therapy—for adults with an IDH-mutated grade 2 or 3 brain tumor. The goal is to see which approach works better and/or causes fewer side effects while treating the tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 65 years old when you sign consent
- Have an IDH-mutated grade 2 or 3 astrocytoma or oligodendroglioma (brain tumor diagnosis)
- Need radiation treatment as part of your care plan
- Be well enough for daily activities (performance status 0–2) and able to get an MRI
- Have little to no “contrast enhancement” on MRI (no more than 1–2 tiny spots)
- Be able to travel for proton therapy if you’re assigned to that group
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests a combination of chemotherapy and radiation after surgery for certain brain tumors that are “IDH wildtype.” It aims to control the tumor and improve outcomes for people with specific types of glioma or glioblastoma.
This study builds and tests how proton therapy planning could better protect the brain compared with standard radiation (photon therapy) for adults with certain brain tumors. It may help reduce radiation to sensitive areas like the hippocampus, with the goal of better long-term brain function.
This trial studies whether delaying radiation therapy helps people with a slow-growing brain tumor called low-grade oligodendroglioma that has specific genetic markers. It compares delayed radiation to standard timing to see which approach controls the tumor with acceptable side effects and quality of life.
This study looks at the short-term results of proton and photon radiation therapy in people with IDH-mutated grade 2 or 3 gliomas. It compares the two types of radiation to see how well they work and what side effects might occur.
This trial compares two types of radiation therapy (proton beams vs. standard photon x-rays) for people with certain slow-growing brain tumors (gliomas) that have a specific gene change. The goal is to see which type better preserves thinking skills and quality of life while treating the tumor.
This trial compares two ways of giving radiation—standard photon radiotherapy (IMRT) versus proton beam therapy—for people with glioblastoma. It may help find a safer or more effective radiation approach for shrinking tumors and improving outcomes.
Hear when a new Oligodendroglioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.